Records containing: Multiple Sclerosis, Primary Progressive
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients With Primary Progressive Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2026-03-19Motor Asymmetry in Progressive Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2026-03-11Randomized Controlled Trial of N-acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-11A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 1, Open-Label, Single Center Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-23A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-03Longitudinal Study of Cognition in Primary Progressive Multiple Sclerosis: a Cohort Study
-
CLINICAL_TRIALS study record update · 2025-12-26Clinnova-MS: a Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-Regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care (Switzerland)
-
CLINICAL_TRIALS study record update · 2025-08-06A Phase 1b, Open-label Study of PIPE-791 to Determine Brain and Lung Lysophosphatidic Acid Receptor 1 (LPA1) Occupancy, by [18F] PIPE-497 PET Imaging in Healthy Volunteers, Volunteers With Progressive Multiple Sclerosis, and Volunteers With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-03-28A Multicenter Phase 1 Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis Using Orca-Q, an Engineered Donor Graft Derived From Mobilized Peripheral Blood
-
CLINICAL_TRIALS study record update · 2025-01-13KYSA-7: A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-09-19The Effects of In-phase Bilateral Exercise on Cognitive and Motor Outcome Measures, in Patients with Progressive Multiple Sclerosis, a Randomized Control Trial.
-
CLINICAL_TRIALS study record update · 2024-06-11A Multicenter Observational Study for Ex-vivo Evaluation of the Likelihood of Response to an Experimental Tolerance Restoration Therapy in Subjects Diagnosed With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2024-06-04An Open-Label, Multicenter, Biomarker Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Patients With Relapsing Multiple Sclerosis or Primary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-02-15Evaluating Task-Oriented Exercise Effects on Walking Function and the Central Nervous System in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-02-06Investigating the Longitudinal Relationships Between Visual Pathway Injury, Radiological and Blood Biomarkers in Multiple Sclerosis and Related Disorders
-
CLINICAL_TRIALS study record update · 2023-11-08Improving Cognition in People With Progressive Multiple Sclerosis: A Multi-Arm, Randomized, Blinded, Sham-Controlled Trial of Cognitive Rehabilitation and Aerobic Exercise.
-
CLINICAL_TRIALS study record update · 2023-03-10Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-09-16Imaging of Intracerebral Inflammation in the Progressive Phase of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-05-23MUSCLE - Nordic and Free Walking in People With Multiple Sclerosis: Clinical-functional, Motor Control, and Gait Analysis Findings: a Randomized Controlled Multicentre Clinical Trials
-
CLINICAL_TRIALS study record update · 2022-04-05Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
-
CLINICAL_TRIALS study record update · 2021-07-30Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Hydroxychloroquine 200mg BID for Reducing Progression of Disability in Patients With Primary Progressive Multiple Sclerosis (PPMS)
-
CLINICAL_TRIALS study record update · 2020-09-11Effect of Aerobic Exercises on Immune System in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-07-28A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-04-28The Effect of Variable Intensity Work on Postural Instability, Motion Performance and Quality of Life in Multiple Sclerosis Patients